Alvotech (ALVO) Current Assets (2020 - 2026)
Alvotech's (ALVO) quarterly Current Assets came in at $545.0 million in Q2 2026, up 6.97% on a YoY basis from $509.5 million in Q2 2025, and up 19.52% quarter-over-quarter from $456.0 million in Q1 2026.
Analysis
Alvotech (ALVO) Current Assets (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Current Assets for 7 consecutive years, with $545.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets rose 6.97% year-over-year to $545.0 million; the trailing twelve-month figure through Jun 2026 stood at $545.0 million (up 6.97% YoY), and the FY2025 full-year result was $574.0 million, up 26.15% from the prior year.
- Current Assets advanced to $545.0 million in Q2 2026 per ALVO's latest filing, from $456.0 million in the prior quarter.
- Across five years, Current Assets topped out at $574.0 million in Q4 2025 and bottomed at $194.8 million in Q4 2023.
- Historically, Current Assets has averaged $381.4 million across 5 years, with a median of $443.8 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Current Assets retreated 15.56% in 2023, then surged 133.53% in 2024.
- Over 5 years, Current Assets stood at $230.7 million in 2022, then declined by 15.56% to $194.8 million in 2023, then soared by 133.53% to $455.0 million in 2024, then grew by 26.15% to $574.0 million in 2025, then fell by 5.06% to $545.0 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $545.0 million, $456.0 million, and $574.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 13.76 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 10.06 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.16 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.95 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 6.52 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 825.43 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 544.97 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 630.95 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 72.50 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | 3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 544.97 Mn |
| Mar 31, 2026 | 455.98 Mn |
| Dec 31, 2025 | 574.02 Mn |
| Sep 30, 2025 | 455.02 Mn |
| Jun 30, 2025 | 509.46 Mn |
| Mar 31, 2025 | 458.87 Mn |
| Dec 31, 2024 | 455.02 Mn |
| Sep 30, 2024 | 432.61 Mn |
| Jun 30, 2024 | 285.19 Mn |
| Mar 31, 2024 | 292.30 Mn |
| Dec 31, 2023 | 194.84 Mn |
| Jun 30, 2023 | 211.91 Mn |
| Dec 31, 2022 | 230.74 Mn |
| Jun 30, 2022 | 238.66 Mn |
| Dec 31, 2021 | 119.82 Mn |
| Dec 31, 2020 | 86.16 Mn |